Skip to main content
. 2014 Jan 13;2014(1):CD003559. doi: 10.1002/14651858.CD003559.pub4

NCT01125748.

Trial name or title A study evaluating the persistency of response with or without Xolair after long‐term therapy (XPORT)
Methods Randomised, double‐blind, parallel‐group study
Participants Patients with allergic asthma 17 to 70 years of age
Interventions Omalizumab versus placebo
Outcomes Severe exacerbation
Starting date May 2010
Contact information http://clinicaltrials.gov/ct2/show/NCT01125748
Notes